{
  "trial_id": "NCT02070991",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, left ventricular dysfunction status, diuretic therapy status, baseline NYHA functional class, baseline pulmonary hypertension classification, baseline fluid retention status, baseline comorbidities, baseline medication use, baseline vital signs, baseline laboratory values.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "New York Heart Association (NYHA) Functional Class at baseline",
          "baseline NYHA functional class"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Time from Left Ventricular Dysfunction (LVD) diagnosis",
        "Time from Combined pre- and post-capillary Pulmonary Hypertension (CpcPH) diagnosis",
        "6-minute walk distance (6MWD) at baseline",
        "Participants with Atrial Fibrillation at baseline",
        "Participants with Diabetes Mellitus Type II",
        "Participants with Right Heart Failure (RHF)",
        "Participants with Systemic Hypertension",
        "Participants with Chronic Kidney Disease (CKD)",
        "Left Ventricular Ejection Fraction (LEVF) at baseline as measured by Investigator",
        "Pulmonary Vascular Resistance (PVR) at baseline",
        "Body Mass Index (BMI) at baseline",
        "Participants with obesity (BMI > 30 kg/m^2)"
      ],
      "remaining_candidate_features": [
        "left ventricular dysfunction status",
        "diuretic therapy status",
        "baseline pulmonary hypertension classification",
        "baseline fluid retention status",
        "baseline comorbidities",
        "baseline medication use",
        "baseline vital signs",
        "baseline laboratory values"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline NYHA Functional Class, Baseline Diuretic Therapy, Baseline Left Ventricular Ejection Fraction (LVEF), Baseline Pulmonary Artery Pressure, Baseline Pulmonary Vascular Resistance, Baseline 6-Minute Walk Distance (6MWD), Baseline BNP/NT-proBNP Levels,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "New York Heart Association (NYHA) Functional Class at baseline",
          "Baseline NYHA Functional Class"
        ],
        [
          "Left Ventricular Ejection Fraction (LEVF) at baseline as measured by Investigator",
          "Baseline Left Ventricular Ejection Fraction (LVEF)"
        ],
        [
          "Pulmonary Vascular Resistance (PVR) at baseline",
          "Baseline Pulmonary Vascular Resistance"
        ],
        [
          "6-minute walk distance (6MWD) at baseline",
          "Baseline 6-Minute Walk Distance (6MWD)"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Time from Left Ventricular Dysfunction (LVD) diagnosis",
        "Time from Combined pre- and post-capillary Pulmonary Hypertension (CpcPH) diagnosis",
        "Participants with Atrial Fibrillation at baseline",
        "Participants with Diabetes Mellitus Type II",
        "Participants with Right Heart Failure (RHF)",
        "Participants with Systemic Hypertension",
        "Participants with Chronic Kidney Disease (CKD)",
        "Body Mass Index (BMI) at baseline",
        "Participants with obesity (BMI > 30 kg/m^2)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Baseline Diuretic Therapy",
        "Baseline Pulmonary Artery Pressure",
        "Baseline BNP/NT-proBNP Levels"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (Customized), Region of Enrollment, Left Ventricular Dysfunction, Pulmonary Hypertension, NYHA Functional Class, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Body Mass Index, Creatinine Clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Left Ventricular Dysfunction",
          "Left Ventricular Dysfunction"
        ],
        [
          "New York Heart Association (NYHA) Functional Class at baseline",
          "NYHA Functional Class"
        ],
        [
          "Body Mass Index (BMI) at baseline",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Time from Left Ventricular Dysfunction (LVD) diagnosis",
        "Time from Combined pre- and post-capillary Pulmonary Hypertension (CpcPH) diagnosis",
        "6-minute walk distance (6MWD) at baseline",
        "Participants with Atrial Fibrillation at baseline",
        "Participants with Diabetes Mellitus Type II",
        "Participants with Right Heart Failure (RHF)",
        "Participants with Systemic Hypertension",
        "Participants with Chronic Kidney Disease (CKD)",
        "Left Ventricular Ejection Fraction (LEVF) at baseline as measured by Investigator",
        "Pulmonary Vascular Resistance (PVR) at baseline",
        "Participants with obesity (BMI > 30 kg/m^2)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Pulmonary Hypertension",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "Creatinine Clearance"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), race, ethnicity, New York Heart Association (NYHA) functional class, left ventricular ejection fraction (LVEF), systolic pulmonary artery pressure (sPAP), diastolic pulmonary artery pressure (dPAP), mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), cardiac output, 6-minute walk distance (6MWD), N-terminal pro-brain natriuretic peptide (NT-proBNP), creatinine, glomerular filtration rate (GFR), liver function tests (LFTs).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "New York Heart Association (NYHA) Functional Class at baseline",
          "New York Heart Association (NYHA) functional class"
        ],
        [
          "6-minute walk distance (6MWD) at baseline",
          "6-minute walk distance (6MWD)"
        ],
        [
          "Left Ventricular Ejection Fraction (LEVF) at baseline as measured by Investigator",
          "left ventricular ejection fraction (LVEF)"
        ],
        [
          "Pulmonary Vascular Resistance (PVR) at baseline",
          "pulmonary vascular resistance (PVR)"
        ],
        [
          "Body Mass Index (BMI) at baseline",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Time from Left Ventricular Dysfunction (LVD) diagnosis",
        "Time from Combined pre- and post-capillary Pulmonary Hypertension (CpcPH) diagnosis",
        "Participants with Atrial Fibrillation at baseline",
        "Participants with Diabetes Mellitus Type II",
        "Participants with Right Heart Failure (RHF)",
        "Participants with Systemic Hypertension",
        "Participants with Chronic Kidney Disease (CKD)",
        "Participants with obesity (BMI > 30 kg/m^2)"
      ],
      "remaining_candidate_features": [
        "systolic pulmonary artery pressure (sPAP)",
        "diastolic pulmonary artery pressure (dPAP)",
        "mean pulmonary artery pressure (mPAP)",
        "cardiac output",
        "N-terminal pro-brain natriuretic peptide (NT-proBNP)",
        "creatinine",
        "glomerular filtration rate (GFR)",
        "liver function tests (LFTs)"
      ]
    }
  }
}